NEXVIADYME subst sèche 100 mg flac 5 pce
7680678710024
CH-67871
A16AB22
07.14.0.
Reimbursement limitations:
NEXVIADYME
Evaluation pour commencer la thérapie avec NEXVIADYME:
Le traitement avec NEXVIADYME de patients atteints d’une …
1 / 3
google
Details
- Product number
- 6787101
- CPT
- -
- Packaging group
- 5
- Unit
- Durchstechflasche(n)
- Composition
- avalglucosidasum alfa 100 mg, histidinum, histidini hydrochloridum monohydricum, glycinum, mannitolum, polysorbatum 80, pro vitro.
Articles (1)
Nexviadyme 100 mg, poudre pour solution à diluer pour perfusion
Puder
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 67871
- Drug name
- Nexviadyme, poudre pour solution à diluer pour perfusion
- Galenic form
- PULPI
- ATC Code
- A16AB22
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 17/11/2021
- Authorization expiration date
- 16/11/2026
- IT number
- 07.14.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NEXVIADYME subst sèche 100 mg flac 5 pce
- Description (DE)
- NEXVIADYME Trockensub 100 mg Durchstf 5 Stk
- Market launch
- 17/11/2021
- Narcotic (BTM)
- No